Incyte to Present at Upcoming Investor Conferences
News > Health News
Audio By Carbonatix
8:00 AM on Tuesday, February 17
The Associated Press
WILMINGTON, Del.--(BUSINESS WIRE)--Feb 17, 2026--
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of March:
- TD Cowen 46 th Annual Health Care Conference on Monday, March 2, 2026 at 10:30 am (EST)
- Leerink Partners 2026 Global Healthcare Conference on Tuesday, March 10, 2026 at 9:20 am (EDT) and
- Barclays 28 th Annual Global Healthcare Conference on Wednesday, March 11, 2026 at 8:30 am (EDT)
The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.
View source version on businesswire.com:https://www.businesswire.com/news/home/20260217945807/en/
CONTACT: Incyte Contacts
Media
KEYWORD: DELAWARE UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL ONCOLOGY
SOURCE: Incyte
Copyright Business Wire 2026.
PUB: 02/17/2026 08:00 AM/DISC: 02/17/2026 08:00 AM
http://www.businesswire.com/news/home/20260217945807/en